Copyright Reports & Markets. All rights reserved.

Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Research Report 2019 by Manufacturers, Regions, Types and Applications

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition
    • 1.2 Manufacturers and Regions Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
    • 1.3 Type Overview
    • 1.4 Application Overview
    • 1.5 Industrial Chain
      • 1.5.1 Castration-Resistant Prostate Cancer (CRPC) Treatment Overall Industrial Chain
      • 1.5.2 Upstream
      • 1.5.3 Downstream
      • 1.5.4 Economic/Political Environment

    2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Assesment by Types

    • 2.1 Overall Market Performance
      • 2.1.1 Product Type Market Performance (Volume)
      • 2.1.2 Product Type Market Performance (Value)
    • 2.2 China Castration-Resistant Prostate Cancer (CRPC) Treatment Market Performance
    • 2.3 USA Castration-Resistant Prostate Cancer (CRPC) Treatment Market Performance
    • 2.4 Europe Castration-Resistant Prostate Cancer (CRPC) Treatment Market Performance
    • 2.5 Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Market Performance
    • 2.6 Korea Castration-Resistant Prostate Cancer (CRPC) Treatment Market Performance
    • 2.7 India Castration-Resistant Prostate Cancer (CRPC) Treatment Market Performance
    • 2.8 Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Market Performance
    • 2.9 South America Castration-Resistant Prostate Cancer (CRPC) Treatment Market Performance

    3 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Assesment by Application

    • 3.1 Overall Market Performance (Volume)
    • 3.2 China Castration-Resistant Prostate Cancer (CRPC) Treatment Market Performance (Volume)
    • 3.3 USA Castration-Resistant Prostate Cancer (CRPC) Treatment Market Performance (Volume)
    • 3.4 Europe Castration-Resistant Prostate Cancer (CRPC) Treatment Market Performance (Volume)
    • 3.5 Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Market Performance (Volume)
    • 3.6 Korea Castration-Resistant Prostate Cancer (CRPC) Treatment Market Performance (Volume)
    • 3.7 India Castration-Resistant Prostate Cancer (CRPC) Treatment Market Performance (Volume)
    • 3.8 Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Market Performance (Volume)
    • 3.9 South America Castration-Resistant Prostate Cancer (CRPC) Treatment Market Performance (Volume)

    4 Competitive Analysis

    • 4.1 Astellas Pharma
      • 4.1.1 Astellas Pharma Profiles
      • 4.1.2 Astellas Pharma Product Information
      • 4.1.3 Astellas Pharma Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue, Price and Gross Margin
      • 4.1.4 Astellas Pharma Castration-Resistant Prostate Cancer (CRPC) Treatment Business Performance
      • 4.1.5 SWOT Analysis
    • 4.2 Johnson & Johnson
      • 4.2.1 Johnson & Johnson Profiles
      • 4.2.2 Johnson & Johnson Product Information
      • 4.2.3 Johnson & Johnson Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue, Price and Gross Margin
      • 4.2.4 Johnson & Johnson Castration-Resistant Prostate Cancer (CRPC) Treatment Business Performance
      • 4.2.5 SWOT Analysis
    • 4.3 Sanofi
      • 4.3.1 Sanofi Profiles
      • 4.3.2 Sanofi Product Information
      • 4.3.3 Sanofi Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue, Price and Gross Margin
      • 4.3.4 Sanofi Castration-Resistant Prostate Cancer (CRPC) Treatment Business Performance
      • 4.3.5 SWOT Analysis
    • 4.4 Valeant
      • 4.4.1 Valeant Profiles
      • 4.4.2 Valeant Product Information
      • 4.4.3 Valeant Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue, Price and Gross Margin
      • 4.4.4 Valeant Castration-Resistant Prostate Cancer (CRPC) Treatment Business Performance
      • 4.4.5 SWOT Analysis
    • 4.5 Dendreon
      • 4.5.1 Dendreon Profiles
      • 4.5.2 Dendreon Product Information
      • 4.5.3 Dendreon Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue, Price and Gross Margin
      • 4.5.4 Dendreon Castration-Resistant Prostate Cancer (CRPC) Treatment Business Performance
      • 4.5.5 SWOT Analysis
    • 4.6 Bayer
      • 4.6.1 Bayer Profiles
      • 4.6.2 Bayer Product Information
      • 4.6.3 Bayer Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue, Price and Gross Margin
      • 4.6.4 Bayer Castration-Resistant Prostate Cancer (CRPC) Treatment Business Performance
      • 4.6.5 SWOT Analysis
    • 4.7 ...
      • 4.7.1 ... Profiles
      • 4.7.2 ... Product Information
      • 4.7.3 ... Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue, Price and Gross Margin
      • 4.7.4 ... Castration-Resistant Prostate Cancer (CRPC) Treatment Business Performance
      • 4.7.5 SWOT Analysis

    5 Competitive Landscape

    • 5.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production (K Units) and Market Share by Manufacturers (2014-2019)
    • 5.2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (M USD) and Market Share by Manufacturers (2014-2019)
    • 5.3 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Price (USD/Unit) of Manufacturers (2014-2019)
    • 5.4 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Gross Margin of Manufacturers (2014-2019)
    • 5.5 Market Concentration

    6 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Assessment by Regions

    • 6.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production (K Units) and Market Share by Regions (2014-2019)
    • 6.2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (M USD) and Market Share by Regions (2014-2019)
    • 6.3 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Price (USD/Unit) by Regions (2014-2019)
    • 6.4 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Gross Margin by Regions (2014-2019)

    7 Castration-Resistant Prostate Cancer (CRPC) Treatment Regional Analysis

    • 7.1 China Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue and Growth Rate (2014-2019)
    • 7.2 USA Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue and Growth Rate (2014-2019)
    • 7.3 Europe Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue and Growth Rate (2014-2019)
    • 7.4 Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue and Growth Rate (2014-2019)
    • 7.5 Korea Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue and Growth Rate (2014-2019)
    • 7.6 India Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue and Growth Rate (2014-2019)
    • 7.7 Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue and Growth Rate (2014-2019)
    • 7.8 South America Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue and Growth Rate (2014-2019)

    8 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption Assessment

    • 8.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption and Market Share by Regions (2014-2019)
    • 8.2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption Value and Market Share by Regions (2014-2019)
    • 8.3 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Average Price (USD/Unit) by Regions (2014-2019)

    9 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Sales Assessment by Regions

    • 9.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Sales Value (2014-2019)
    • 9.2 China Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Sales Value (2014-2019)
    • 9.3 USA Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Sales Value (2014-2019)
    • 9.4 Europe Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Sales Value (2014-2019)
    • 9.5 Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Sales Value (2014-2019)
    • 9.6 Korea Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Sales Value (2014-2019)
    • 9.7 India Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Sales Value (2014-2019)
    • 9.8 Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Sales Value (2014-2019)
    • 9.9 South America Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Sales Value (2014-2019)

    10 Technology and Cost

    • 10.1 Technology
    • 10.2 Cost

    11 Channel Analysis

    • 11.1 Market Channel
    • 11.2 Distributors

    12 Market Forecast 2020-2025

    • 12.1 Production and Revenue Forecast 2020-2025
      • 12.1.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production and Revenue by Regions 2020-2025
      • 12.1.2 China Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue and Growth Rate 2020-2025
      • 12.1.3 USA Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue and Growth Rate 2020-2025
      • 12.1.4 Europe Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue and Growth Rate 2020-2025
      • 12.1.5 Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue and Growth Rate 2020-2025
      • 12.1.6 Korea Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue and Growth Rate 2020-2025
      • 12.1.7 India Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue and Growth Rate 2020-2025
      • 12.1.8 Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue and Growth Rate 2020-2025
      • 12.1.9 South America Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue and Growth Rate 2020-2025
    • 12.2 Sales and Sales Value Forecast 2020-2025
      • 12.2.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption and Consumption Calue by Regions 2020-2025
      • 12.2.2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Sales Value Forecast 2020-2025
      • 12.2.3 China Castration-Resistant Prostate Cancer (CRPC) Treatment Sales, Sales Value and Growth Rate 2020-2025
      • 12.2.4 USA Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Sales Value Forecast 2020-2025
      • 12.2.5 Europe Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Sales Value Forecast 2020-2025
      • 12.2.6 Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Sales Value Forecast 2020-2025
      • 12.2.7 Korea Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Sales Value Forecast 2020-2025
      • 12.2.8 India Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Sales Value Forecast 2020-2025
      • 12.2.9 Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Sales Value Forecast 2020-2025
      • 12.2.10 South America Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Sales Value Forecast 2020-2025
    • 12.3 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production and Revenue Forecast by Type 2020-2025
      • 12.3.1 Overall Market Performance
      • 12.3.2 Chemotherapy
      • 12.3.3 Hormonal Therapy
      • 12.3.4 Immunotherapy
      • 12.3.5 Radiotherapy
    • 12.4 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Sales Forecast by Application 2020-2025
      • 12.4.1 Overall Market Performance
      • 12.4.2 Hospitals
      • 12.4.3 Clinics
      • 12.4.4 Others
    • 12.5 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Price and Gross Margin Forecast
      • 13.5.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Averages Price Development Trend Forecast 2020-2025
      • 13.5.2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Gross Margin Development Trend Forecast 2020-2025

    13 Conclusion

    Geographically, global Castration-Resistant Prostate Cancer (CRPC) Treatment market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Astellas Pharma
    Johnson & Johnson
    Sanofi
    Valeant
    Dendreon
    Bayer
    ...

    On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
    Chemotherapy
    Hormonal Therapy
    Immunotherapy
    Radiotherapy
    For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Castration-Resistant Prostate Cancer (CRPC) Treatment for each application, including
    Hospitals
    Clinics
    Others
    Production, consumption, revenue, market share and growth rate are the key targets for Castration-Resistant Prostate Cancer (CRPC) Treatment from 2013 to 2024 (forecast) in these regions
    China
    USA
    Europe
    Japan
    Korea
    India
    Southeast Asia
    South America

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now